Neoadjuvant Therapy of HAIC（GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
Clinical trial NCT06208462 · RECRUITING
Trial details
- NCT number
- NCT06208462
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-19
- Primary completion
- 2026-01-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.